NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

• Amit K. Pandey ,

  Contributed equally to this work with: Amit K. Pandey, Yibin Yang

  Affiliation Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Yibin Yang ,

  Contributed equally to this work with: Amit K. Pandey, Yibin Yang

  Affiliation Department of Cancer Biology and the Immunology and Virology Program, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Zhaozhao Jiang,

  Affiliation Department of Medicine and the Immunology and Virology Program, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Sarah M. Fortune,

  Affiliation Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Francois Coulombe,

  Affiliation Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada

  ⨯
• Marcel A. Behr,

  Affiliation Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada

  ⨯
• Katherine A. Fitzgerald,

  Affiliation Department of Medicine and the Immunology and Virology Program, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Christopher M. Sassetti ,

  * E-mail: christopher.sassetti@umassmed.edu (CMS); michelle.kelliher@umassmed.edu (MAK)

  Affiliation Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Michelle A. Kelliher

  * E-mail: christopher.sassetti@umassmed.edu (CMS); michelle.kelliher@umassmed.edu (MAK)

  Affiliation Department of Cancer Biology and the Immunology and Virology Program, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯